> ## Content Index
> Fetch the complete content index at: https://www.coios.me/llms.txt
> Use this file to discover other available public pages before exploring further.

# Denosumab discontinuation in Japan is rarely followed by sequential osteoporosis therapy
- URL: https://www.coios.me/denosumab-discontinuation-in-japan-is-rarely-followed-by/
- Published: 2026-11-15T11:39:22.000Z
- Updated: 2026-11-15T12:24:22.000Z
- Description: Of 37,526 Japanese adults who stopped denosumab, 16.3% began sequential osteoporosis therapy within one year.
- Author: Daniel Ryan
- Tags: Behavioural science, Adherence and persistence, Japan, #peer-reviewed, #confirms, #item, #source-2026-11, #score-65

This descriptive study used a Japanese claims database covering April 2014 to March 2024\. It included 37,526 adults aged 40 or over who started denosumab and stopped after at least two doses. Stopping meant a gap of more than 240 days after the last dose. Within a year, 29.6% resumed denosumab after that gap, 50.9% had no further treatment and 16.3% began sequential therapy. Oral bisphosphonates (26.7%) and romosozumab (22.2%) were the commonest sequential therapies. The study did not compare fracture risk between treatment patterns, though 5.4% had a fragility fracture within a year.

*Why it is interesting: Half of patients who stopped denosumab had no further osteoporosis treatment within a year. Timing differed by drug, with romosozumab most often started 180-209 days after stopping.*

Source

[Archives of Osteoporosis, 12 November 2026](https://doi.org/10.1007/s11657-026-01812-8?ref=coios.me)

Paper

Real-world treatment patterns following denosumab discontinuation: a descriptive epidemiological study

Authors

Yoshiyama T, Fukasawa T, Masuda S, Matsuda S, Kawakami K

DOI

10.1007/s11657-026-01812-8

Type

Peer-reviewed article

Design

Descriptive cohort in a Japanese claims database, 37,526 adults aged 40+ newly initiating denosumab and discontinuing after ≥2 doses, April 2014-March 2024, 1-year follow-up

Verdict

Confirms prior evidence

Driver

[Adherence and persistence](https://www.coios.me/d-adherence/)